Osteopenic effects of MgSO4 in multiple pregnancies

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 10, 2006, Pages 1225-1230

  Kaplan, Walid ^a   Haymond, Morey W ^a,b   McKay, Siripoom ^a   Karaviti, Lefkothea P ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Hypermagnesemia; Hypocalcemia; Osteopenia; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; INDOMETACIN; MAGNESIUM; MAGNESIUM SULFATE; TERBUTALINE; BONE DENSITY CONSERVATION AGENT;

ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CASE STUDY; CHILD CARE; DOSE RESPONSE; FOLLOW UP; HUMAN; HYPERMAGNESEMIA; HYPOCALCEMIA; INFANT; MULTIPLE PREGNANCY; OSTEOPENIA; PREGNANCY; PREMATURE LABOR; PREMATURITY; RIB FRACTURE; TREATMENT OUTCOME; ADULT; BLOOD; BONE; CHEMICALLY INDUCED DISORDER; FEMALE; METABOLIC BONE DISEASE; NEWBORN; RADIOGRAPHY;

ADULT; ALKALINE PHOSPHATASE; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCITRIOL; CALCIUM; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MAGNESIUM; MAGNESIUM SULFATE; PREGNANCY; PREGNANCY, MULTIPLE;

EID: 37849186509     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hill WC. Risks and complications of tocolysis. Clin Obstet Gynecol 1995; 38: 725-745.
2. Gordon MC, Iams D. Magnesium sulfate. Clin Obstet Gynecol 1995; 38: 706-712.
3. Ramsey PS, Rouse DJ. Magnesium sulfate as a tocolytic agent. Semin Perinatol 2001; 25: 236-247.
4. Cruikshank DP, Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses. Am J Obstet Gynecol 1979; 134: 243-249.
5. Rantonen T, Kaapa P, Jalonen J, Ekblad U, Peltola O, Valimaki I, Kero P. Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates. Acta Paediatr 2001; 90: 278-281.
6. Lamm CI, Norton KI, Murphy RJ, Wilkins IA, Rabinowitz JG. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988; 113: 1078-1082.
7. Santi MD, Henry GW, Douglas GL. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994; 14: 249-253.
8. Matsuda Y, Maeda Y, Ito M, Sakamoto H, Masaoka N, Takada M, Sato K. Effect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest 1997; 44: 82-88.
9. Cruikshank DP, Chan GM, Doerrfeld D. Alterations in vitamin D and calcium metabolism with magnesium sulfate treatment of preeclampsia. Am J Obstet Gynecol 1993; 168: 1170-1176.
10. Smith LG Jr, Burns PA, Schanler RJ. Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm labor. Am J Obstet Gynecol 1992; 167: 45-51.
11. Hung JW, Tsai MY, Yang BY, Chen JF. Maternal osteoporosis after prolonged magnesium sulfate tocolysis therapy: a case report. Arch Phys Med Rehabil 2005; 86: 146-149.
12. Demarini S, Memooni FB, Tsang RC. Disorders of Calcium, Phosphorus, and Magnesium Metabolism. St. Louis, MO: Mosby, 1997; 1473.
13. Beyers N, Alheit B, Taljaard JF, Hall JM, Hough SF. High turnover osteopenia in preterm babies. Bone 1994; 15: 5-13.
14. Mora S, Weber G, Bellini A, Bianchi C, Chiumello G. Bone modeling alteration in premature infants. Arch Pediatr Adolesc Med 1994; 148: 1215-1217.
15. Payne WW, Acharya PT. The effect of abnormal birth on blood chemistry during the first 48 hours of life. Arch Dis Child 1965; 40: 436-441.
16. Bistarakis L, Voskaki I, Lambadaridis J, Sereti H, Sbyrakis S. Renal handling of phosphate in the first six months of life. Arch Dis Child 1986; 61: 677-681.
17. Tsang RC, Light IJ, Sutherland JM, Kleinman LI. Possible pathogenetic factors in neonatal hypocalcemia of prematurity. The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness. J Pediatr 1973; 82: 423-429.
18. Miller ME. The bone disease of preterm birth: a biomechanical perspective. Pediatr Res 2003; 53: 10-15.
19. Avery GB, Fletcher M, MacDonald MG. Neonatology, Pathophysiology and the Management of the Newborn. Philadelphia, PA: J.B. Lipincott, 1999; 732.
20. Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310: 1221-1225.
21. Schanler RJ, Smith LG Jr, Burns PA. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest 1997; 43: 236-241.
22. Quamme GA, Carney SL, Wong NL, Dirks JH. Effect of parathyroid hormone on renal calcium and magnesium reabsorption in magnesium deficient rats. Pflug Arch 1980; 386: 59-65.
23. Donovan EF, Tsang RC, Steichen JJ, Strub RJ, Chen IW, Chen M. Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis. J Pediatr 1980; 96: 305-310.
24. Marx SJ, Spiegel AM, Brown EM, Koehler JO, Gardner DG, Brennan MF, Aurbach GD. Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 1978; 65: 235-242.
25. 820Phe) in the calcium-sensing receptor. J Clin Endocrinol Metab 2002; 87: 2681-2687.